German drug firm in 4.4bn euro deal
613574
German drug firm Schwarz Pharma is being bought in a 4.4bn euro deal, the third industry tie-up in recent days.
227772
The pharmaceutical sells European rights to a promising asthma drug.
555013
The pharmaceutical firm releases fourth-quarter financials.
287707
Serono SA , one of the world's largest biotechnology companies, was bought yesterday by German chemical giant Merck KGaA in a deal worth more than $13 billion.
110719
German drugmaker Merck MRCG.DE on   Thursday agreed to buy a 64.5 percent stake in rival Serono   SEO.VX in a surprise deal valued over 10 billion Swiss francs   ($8.3 billion), creating a new force in European   pharmaceuticals.
182171
Deals worth nearly 15bn euros have boosted share prices as Europe's pharmaceuticals sector consolidates further.
503451
Lanxess AG, the spun-off chemicals and polymers business of German drug maker Bayer AG, made its debut on the Frankfurt stock exchange today.
319966
German state banking group KfW is selling up to 4 billion euros (2.8 billion pounds) worth of shares in Deutsche Telekom, continuing the privatisation of the German phone operator.
653679
The EU market welcomes the drugmaker's copy of a treatment for anemia.
71950
Schering-Plough Corp  has agreed to buy Akzo Nobel NV's  drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.
312810
Allianz AG, Europe s largest insurer, will sell exchangeable and subordinated bonds worth about 4 billion euros ($5.2 billion) to boost capital, cut debt and reduce the company s investments in German equities.
700315
German drugmaker Merck KGaA   unveiled a surprise 16.6-billion-Swiss franc ($13.3  billion) deal to buy Swiss biotech firm Serono on Thursday,  creating a new force in European pharmaceuticals.
363655
Business software maker completes fourth round of funding.
693054
Bayer AG, Germany&#39;s second-biggest drug and chemical maker, formed a partnership with US rival Schering-Plough Corp. to market some of Bayer&#39;s biggest medicines after sales lagged in the second quarter.
142333
German chemicals and pharmaceuticals giant Bayer said it had acquired the marketing rights for GlaxoSmithKline's erectile dysfunction treatment Levitra in a number of countries outside the US for 208 million euros (272 million dollars).
320595
Belgian biopharmaceutical group UCB has announced a friendly takeover bid of 4.4 billion euros (5.6 billion dollars) for German company Schwarz Pharma, aimed at strengthening its position in the neurology sector.
217896
FRANKFURT Bayer said Monday that it had formed a partnership with Schering-Plough to market some of its biggest drugs in the United States.